A novel FTY720 analogue targets SET-PP2A interaction and inhibits growth of acute myeloid leukemia cells without inducing cardiac toxicity.
Vicente C, Arriazu E, Mart?nez-Balsalobre E, Peris I, Marcotegui N, Garc?a-Ram?rez P, Pippa R, Rabal O, Oyarz?bal J, Guruceaga E, Pr?sper F, Mateos MC, Cayuela ML, Odero MD. A novel FTY720 analogue targets SET-PP2A interaction and inhibits growth of acute myeloid leukemia cells without inducing cardiac toxicity. Cancer Lett. 2020 01 01; 468:1-13.